郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Novel pyridylmethylamines as highly selective 5-HT(1A) superagonists.

期刊：Journal of medicinal chemistry发表年份：2010作者：Stefan Bollinger; Harald Hübner; Frank W Heinemann; Karsten Meyer; Peter Gmeiner
阅读更多 →

药效评价In vitro and in vivo assessment of mu opioid receptor constitutive activity.

期刊：Methods in enzymology发表年份：2010作者：Edward J Bilsky; Denise Giuvelis; Melissa D Osborn; Christina M Dersch; Heng Xu; Richard B Rothman
阅读更多 →

药效评价Using electrophysiology and in silico three-dimensional modeling to reduce human Ether-à-go-go related gene K(+) channel inhibition in a histamine H3 receptor antagonist program.

期刊：Assay and drug development technologies发表年份：2010作者：Adam J Davenport; Clemens Möller; Alexander Heifetz; Michael P Mazanetz; Richard J Law; Andreas Ebneth; Mark J Gemkow
阅读更多 →

药效评价The distinctive separation attributes of mixed-mode resins and their application in monoclonal antibody downstream purification process.

期刊：Journal of chromatography. A发表年份：2010作者：Jie Chen; Jen Tetrault; Yanyu Zhang; Andy Wasserman; Greg Conley; Mike Dileo; Elliot Haimes; Andrew E Nixon; Arthur Ley
阅读更多 →